|
🐬
|
Safe Feature Elimination in Sparse Supervised Learning
L. Ghaoui,
V. Viallon,
T. Rabbani
|
7 |
2010 |
7
🐬
|
|
🐜
|
Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study
56 auth.
H. Freisling,
V. Viallon,
H. Lennon,
V. Bagnardi,
C. Ricci,
A. Butterworth,
M. Sweeting,
D. Muller,
I. Romieu,
Pauline Bazelle,
M. Kvaskoff,
P. Arveux,
G. Severi,
C. Bamia,
T. Kühn,
...
R. Kaaks,
M. Bergmann,
H. Boeing,
A. Tjønneland,
A. Olsen,
K. Overvad,
C. Dahm,
V. Menéndez,
A. Agudo,
M. Sánchez,
M. Sánchez,
P. Amiano,
Carmen Santiuste,
A. B. Gurrea,
T. Tong,
Julie A. Schmidt,
I. Tzoulaki,
I. Tzoulaki,
K. Tsilidis,
K. Tsilidis,
Heather A. Ward,
D. Palli,
C. Agnoli,
R. Tumino,
F. Ricceri,
S. Panico,
H. Picavet,
M. Bakker,
E. Monninkhof,
P. Nilsson,
J. Manjer,
O. Rolandsson,
Elin Thysell,
E. Weiderpass,
M. Jenab,
E. Riboli,
P. Vineis,
J. Danesh,
N. Wareham,
M. Gunter,
P. Ferrari
|
7 |
2020 |
7
🐜
|
|
🐜
|
Association Between Soft Drink Consumption and Mortality in 10 European Countries
52 auth.
Amy Mullee,
Amy Mullee,
D. Romaguera,
Jonathan Pearson-Stuttard,
V. Viallon,
M. Stepien,
H. Freisling,
G. Fagherazzi,
F. Mancini,
M. Boutron‐Ruault,
T. Kühn,
R. Kaaks,
H. Boeing,
K. Aleksandrova,
A. Tjønneland,
...
J. Halkjær,
K. Overvad,
E. Weiderpass,
G. Skeie,
C. Parr,
J. Quirós,
A. Agudo,
M. Sánchez,
P. Amiano,
L. Cirera,
E. Ardanaz,
K. Khaw,
T. Tong,
Julie A. Schmidt,
A. Trichopoulou,
G. Martimianaki,
A. Karakatsani,
D. Palli,
C. Agnoli,
R. Tumino,
C. Sacerdote,
S. Panico,
B. Bueno-de-Mesquita,
W. Verschuren,
J. Boer,
R. Vermeulen,
S. Ramne,
E. Sonestedt,
B. Guelpen,
P. Holgersson,
K. Tsilidis,
K. Tsilidis,
A. Heath,
D. Muller,
E. Riboli,
M. Gunter,
N. Murphy
|
7 |
2019 |
7
🐜
|
|
🐜
|
Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit*
11 auth.
F. Pène,
Stéphanie Percheron,
V. Lemiale,
V. Viallon,
Y. Claessens,
S. Marqué,
...
J. Charpentier,
D. Angus,
A. Cariou,
J. Chiche,
J. Mira
|
7 |
2008 |
7
🐜
|
|
🐬
|
Safe Feature Elimination for the LASSO and Sparse Supervised Learning Problems
L. Ghaoui,
V. Viallon,
T. Rabbani
|
7 |
2010 |
7
🐬
|
|
🐜
|
A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA
12 auth.
F. Campeotto,
A. Suau,
N. Kapel,
F. Magne,
V. Viallon,
L. Ferraris,
...
A. Waligora-Dupriet,
P. Soulaines,
B. Leroux,
N. Kalach,
C. Dupont,
M. Butel
|
6 |
2011 |
6
🐜
|
|
🐬
|
Cannabis, alcohol and fatal road accidents
Jean-Louis Martin,
B. Gadegbeku,
Dan Wu,
V. Viallon,
B. Laumon
|
6 |
2017 |
6
🐬
|
|
🐜
|
Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study
35 auth.
R. Córdova,
V. Viallon,
E. Fontvieille,
Laia Peruchet-Noray,
A. Jansana,
Karl-Heinz Wagner,
C. Kyrø,
A. Tjønneland,
V. Katzke,
Rashmita Bajracharya,
Matthias B. Schulze,
G. Masala,
S. Sieri,
S. Panico,
F. Ricceri,
...
R. Tumino,
J. Boer,
W. Verschuren,
Y. T. van der Schouw,
P. Jakszyn,
D. Redondo-Sánchez,
P. Amiano,
J. Huerta,
Marcela Guevara,
Y. Borné,
E. Sonestedt,
K. Tsilidis,
Christopher Millett,
A. Heath,
E. Aglago,
D. Aune,
M. Gunter,
P. Ferrari,
I. Huybrechts,
H. Freisling
|
6 |
2023 |
6
🐜
|
|
🐜
|
Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's).
13 auth.
C. Espy,
W. Morelle,
N. Kavian,
P. Grange,
C. Goulvestre,
V. Viallon,
C. Chéreau,
C. Pagnoux,
J. Michalski,
L. Guillevin,
...
B. Weill,
F. Batteux,
P. Guilpain
|
6 |
2011 |
6
🐜
|
|
🐬
|
Predictiveness curves in virtual screening
Charly Empereur-mot,
Hélène Guillemain,
A. Latouche,
J. Zagury,
V. Viallon,
M. Montès
|
6 |
2015 |
6
🐬
|
